KR100627532B1 - Hiv 역전사효소 억제제로서의 피라졸 유도체 - Google Patents

Hiv 역전사효소 억제제로서의 피라졸 유도체 Download PDF

Info

Publication number
KR100627532B1
KR100627532B1 KR1020037015833A KR20037015833A KR100627532B1 KR 100627532 B1 KR100627532 B1 KR 100627532B1 KR 1020037015833 A KR1020037015833 A KR 1020037015833A KR 20037015833 A KR20037015833 A KR 20037015833A KR 100627532 B1 KR100627532 B1 KR 100627532B1
Authority
KR
South Korea
Prior art keywords
methyl
isopropyl
pyridyl
dichlorophenylthio
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020037015833A
Other languages
English (en)
Korean (ko)
Other versions
KR20040003050A (ko
Inventor
다이모크브라이언윌리엄
길아드리안리암
존스필립스티븐
파케스케빈에드워드버든
파라트마틴존
Original Assignee
에프. 호프만-라 로슈 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에프. 호프만-라 로슈 아게 filed Critical 에프. 호프만-라 로슈 아게
Publication of KR20040003050A publication Critical patent/KR20040003050A/ko
Application granted granted Critical
Publication of KR100627532B1 publication Critical patent/KR100627532B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
KR1020037015833A 2001-06-04 2002-05-29 Hiv 역전사효소 억제제로서의 피라졸 유도체 Expired - Fee Related KR100627532B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0113524.3A GB0113524D0 (en) 2001-06-04 2001-06-04 Pyrazole derivatives
GB0113524.3 2001-06-04
PCT/EP2002/005898 WO2002100853A1 (en) 2001-06-04 2002-05-29 Pyrazole derivatives as hiv reverse transcriptase inhibitors

Publications (2)

Publication Number Publication Date
KR20040003050A KR20040003050A (ko) 2004-01-07
KR100627532B1 true KR100627532B1 (ko) 2006-09-21

Family

ID=9915841

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020037015833A Expired - Fee Related KR100627532B1 (ko) 2001-06-04 2002-05-29 Hiv 역전사효소 억제제로서의 피라졸 유도체

Country Status (17)

Country Link
US (1) US6538015B1 (cg-RX-API-DMAC10.html)
EP (1) EP1401826B1 (cg-RX-API-DMAC10.html)
JP (1) JP4088249B2 (cg-RX-API-DMAC10.html)
KR (1) KR100627532B1 (cg-RX-API-DMAC10.html)
CN (1) CN1249052C (cg-RX-API-DMAC10.html)
AT (1) ATE357439T1 (cg-RX-API-DMAC10.html)
AU (1) AU2002325221B2 (cg-RX-API-DMAC10.html)
BR (1) BR0210158A (cg-RX-API-DMAC10.html)
CA (1) CA2448058C (cg-RX-API-DMAC10.html)
DE (1) DE60219009T2 (cg-RX-API-DMAC10.html)
DK (1) DK1401826T3 (cg-RX-API-DMAC10.html)
ES (1) ES2282446T3 (cg-RX-API-DMAC10.html)
GB (1) GB0113524D0 (cg-RX-API-DMAC10.html)
MX (1) MXPA03011199A (cg-RX-API-DMAC10.html)
PT (1) PT1401826E (cg-RX-API-DMAC10.html)
WO (1) WO2002100853A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA200308781B (cg-RX-API-DMAC10.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200423930A (en) * 2003-02-18 2004-11-16 Hoffmann La Roche Non-nucleoside reverse transcriptase inhibitors
JP4993407B2 (ja) 2004-08-04 2012-08-08 大正製薬株式会社 トリアゾール誘導体
CA2592909A1 (en) * 2005-01-06 2006-07-13 Pfizer Limited Imidazole derivatives as enzyme reverse transcriptase modulators
PL1988083T3 (pl) 2006-02-03 2014-08-29 Taisho Pharmaceutical Co Ltd Pochodna triazolowa
RU2395499C2 (ru) 2006-02-06 2010-07-27 Тайсо Фармасьютикал Ко., Лтд. Ингибитор связывания сфингозин-1-фосфата
DE602007013573D1 (de) 2006-08-16 2011-05-12 Hoffmann La Roche Nicht-nukleosidische reverse-transkriptase-hemmer
WO2009000663A1 (en) 2007-06-22 2008-12-31 F. Hoffmann-La Roche Ag Urea and carbamate derivatives as non-nucleoside reverse transcriptase inhibitors
ATE554070T1 (de) 2007-08-01 2012-05-15 Taisho Pharmaceutical Co Ltd Hemmer der s1p1-bindung
AU2008340422B2 (en) 2007-12-21 2014-06-19 F. Hoffmann-La Roche Ag Heterocyclic antiviral compounds
DE102008015033A1 (de) 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung
DE102008015032A1 (de) 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte Pyrazolamide und ihre Verwendung
DE102008062863A1 (de) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituierte (Thiophenyl-carbonyl)imidazolidinone und ihre Verwendung
DE102008062878A1 (de) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituierte Furancarboxamide und ihre Verwendung
EP2295038B1 (en) * 2009-09-11 2013-05-29 AiCuris GmbH & Co. KG Solid dispersion comprising an anti-HIV agent
WO2011144549A1 (en) * 2010-05-20 2011-11-24 Bayer Cropscience Ag Method for manufacturing 1 - alkyl - 3 - difluormethyl - 5 - hydroxypyrazoles
ES2565193T3 (es) 2010-07-15 2016-04-01 Sumitomo Dainippon Pharma Co., Ltd. Compuesto de pirazol
US9695127B2 (en) 2012-11-08 2017-07-04 University of Pittsburgh—of the Commonwealth System of Higher Education Compounds for treating HIV and methods for using the compounds
US9925190B2 (en) 2015-02-16 2018-03-27 University of Pittsburgh—of the Commonwealth System of Higher Education Small molecules targeting HIV-1 Nef

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993015060A1 (fr) 1992-01-22 1993-08-05 Nissan Chemical Industries, Ltd. Derive de pyrazole substitue et bactericide agrohorticole
US6005109A (en) 1997-10-30 1999-12-21 Pflizer Inc. Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
BR9509024A (pt) 1994-09-26 1997-09-30 Shionogi & Co Derivados de imidazol
US5698495A (en) 1995-11-15 1997-12-16 Zeneca Limited Herbicidal substituted pyrazole compounds
GB0016787D0 (en) 2000-07-07 2000-08-30 Pfizer Ltd Compounds useful in therapy
GB0024795D0 (en) 2000-10-10 2000-11-22 Hoffmann La Roche Pyrazole derivatives for the treatment of viral diseases

Also Published As

Publication number Publication date
MXPA03011199A (es) 2004-02-26
EP1401826B1 (en) 2007-03-21
DE60219009D1 (de) 2007-05-03
JP4088249B2 (ja) 2008-05-21
DK1401826T3 (da) 2007-07-30
CN1527829A (zh) 2004-09-08
ATE357439T1 (de) 2007-04-15
US6538015B1 (en) 2003-03-25
CN1249052C (zh) 2006-04-05
CA2448058A1 (en) 2002-12-19
JP2004532276A (ja) 2004-10-21
DE60219009T2 (de) 2007-12-13
AU2002325221B2 (en) 2008-07-31
CA2448058C (en) 2008-12-23
BR0210158A (pt) 2004-06-08
WO2002100853A1 (en) 2002-12-19
GB0113524D0 (en) 2001-07-25
KR20040003050A (ko) 2004-01-07
EP1401826A1 (en) 2004-03-31
PT1401826E (pt) 2007-06-19
ES2282446T3 (es) 2007-10-16
ZA200308781B (en) 2005-02-11

Similar Documents

Publication Publication Date Title
KR20040003050A (ko) Hiv 역전사효소 억제제로서의 피라졸 유도체
KR0182798B1 (ko) 피라졸 유도체,이의 제조방법 및 이를 함유한 약학조성물
KR101139314B1 (ko) 피리미도티오펜 화합물
ES2358335T3 (es) Derivados de piridazin-3(2h)-ona y su uso como inhibidores de pde4.
AU778374B2 (en) 1-(aminophenyl)-2-pyrrolidones as integrin inhibitors
KR100776093B1 (ko) 비-뉴클레오사이드 역전사효소 억제제
AU2002325221A1 (en) Pyrazole Derivatives as HIV Reverse Transcriptase Inhibitors
DE69704060T2 (de) Tetrahydroisochinolinderivate und ihre pharmazeutische anwendung
KR20090108726A (ko) 11-β-HSD1 억제제로서 피라졸 유도체
KR100549884B1 (ko) 에이즈 치료용 피롤 유도체
KR20140090166A (ko) 케모카인-매개 병태 치료에 사용되는 이치환된 3,4-디아미노-3-시클로부텐-1,2-디온 화합물
MXPA05000336A (es) Antagonistas del receptor 1 de hormona de concentracion de melanina (mchir).
CN119137112A (zh) 喹啉cGAS拮抗剂化合物
AU2001263874A1 (en) Pyrrole derivatives for treating aids
KR101109948B1 (ko) 신규 이미다졸 유도체, 그의 제조 방법 및 그의 약제로서의용도
DE60318874T2 (de) Pyrazolderivate
EP1341766B1 (en) Imidazolone derivatives for the treatment of viral diseases
US7250521B2 (en) Method for production of Δ1-pyrrolines
Sova et al. Synthesis and biological evaluation of N-aryl-N’-(5-(2-hydroxybenzoyl) pyrimidin-2-yl) guanidines as toll-like receptor 4 antagonists

Legal Events

Date Code Title Description
A201 Request for examination
AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

J201 Request for trial against refusal decision
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PJ0201 Trial against decision of rejection

St.27 status event code: A-3-3-V10-V11-apl-PJ0201

PB0901 Examination by re-examination before a trial

St.27 status event code: A-6-3-E10-E12-rex-PB0901

B701 Decision to grant
PB0701 Decision of registration after re-examination before a trial

St.27 status event code: A-3-4-F10-F13-rex-PB0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20090916

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20090916

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000